108
Participants
Start Date
July 31, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
February 29, 2012
Meals during hemodialysis accompanied by lanthanum carbonate to control phosphorus
Based on the hypothesis that the efficacy and potency of Fosrenol enables increasing dietary protein intake and provision of meals during dialysis treatment for improving nutritional status in malnourished dialysis patients with a low serum albumin (\<4.0 g/dL) while serum phosphorus can be effectively controlled with the target range of 3.5 to 5.5 mg/dL
Collaborators (1)
DaVita, Inc.
INDUSTRY
Shire
INDUSTRY
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER